Ampligen: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Ampligen''' the tradename for ''' | '''Ampligen''' the tradename for '''rintatolimod''' is a mismatched, double-stranded RNA molecule with immunomodulatory and antiviral properties. The drug acts as a [[TLR3]] agonist which stimulates the production of [[interferons]] and [[tumor necrosis factors]]. | ||
It has been shown to raise [[natural killer cell]] function.<ref>Reference needed</ref> | It has been shown to raise [[natural killer cell]] function.<ref>Reference needed</ref> | ||
Revision as of 07:40, December 15, 2015
Ampligen the tradename for rintatolimod is a mismatched, double-stranded RNA molecule with immunomodulatory and antiviral properties. The drug acts as a TLR3 agonist which stimulates the production of interferons and tumor necrosis factors.
It has been shown to raise natural killer cell function.[1]
<References>
- ↑ Reference needed
